# The Efficacy and Safety of Sanfujiu on Patients With Persistent Allergic Rhinitis: Randomized Controlled Study

> **NCT02192645** · PHASE3 · UNKNOWN · sponsor: **Guangdong Provincial Hospital of Traditional Chinese Medicine** · enrollment: 453 (estimated)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Sanfujiu
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02192645
- **Lead sponsor:** Guangdong Provincial Hospital of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-07
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 453 (ESTIMATED)
- **Last updated:** 2017-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02192645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02192645, "The Efficacy and Safety of Sanfujiu on Patients With Persistent Allergic Rhinitis: Randomized Controlled Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02192645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*